AstraZeneca Warns German Healthcare Reforms Threaten Access to Cutting-Edge Cancer Treatments
AstraZeneca cautions that German healthcare reforms aimed at cost savings may limit access to innovative cancer treatments, risking patient care and pharmaceutical investment.